跳至主要内容
临床试验/NCT05223764
NCT05223764已完成不适用

Why Are They Not Coming Back? A Single-center Follow-up Study in Fertility Preservation in Oncological Women.

Istituto Clinico Humanitas1 个研究点 分布在 1 个国家目标入组 172 人开始时间: 2021年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
172
试验地点
1
主要终点
return rate

研究概览

简要总结

This is a single-center retrospective study carried out with a phone call follow-up to investigate women's decision not to return for criopreserved ovocytes use after cancer treatment. The study database includes all women who underwent fertility preservation cycles at a third-level university-affiliated center from January 2001 to December 2017.

Patients were asked a set of standardized questions whose purpose was to investigate their present health conditions, cancer treatment and any potential relapses, their family projects and sentimental status, any spontaneous conception, and why they had not yet returned for embryo transfer.

All data were recorded anonymously in our dataset.

详细描述

All women who underwent oocyte cryopreservation cycles for oncological purposes from January 2001 to December 2017 at Fertility Center of Humanitas Research Hospital, Rozzano (Milano), Italy, were contacted.

The survey's purpose was to investigate their present health conditions, cancer treatment and any potential relapses, their family projects and sentimental status, any spontaneous conception, and why they had not yet returned for oocytes use.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •The study database includes all women who underwent fertility preservation cycles at a third-level university-affiliated center

排除标准

  • 未提供

结局指标

主要结局

return rate

时间窗: from January 2001 to December 2021

return rate of cancer patients who underwent fertility preservation

次要结局

未报告次要终点

研究者

发起方
Istituto Clinico Humanitas
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

已完成
不适用
A descriptive study of Relapsing-Remitting Multiple Sclerosis (RRMS) treated with first disease modifying therapies (DMTs) in current UK clinical practice: patterns of clinical decision making and the patient experience of relapseNervous System DiseasesMultiple SclerosisMultiple sclerosis
ISRCTN66678006ovartis Pharmaceuticals Ltd (UK)150
已完成
不适用
A multicenter, observational study for reactivation of hepatitis B virus by means of serial HBV-DNA monitoring during and just after systemic chemotherapy containing rituximab plus steroid for malignant lymphoma (C-SHOT 0802)ntreated CD20-positive, B-cell non-Hodgkin's lymphoma in the patients with seronegativity for HBsAg and seropositivity for HBc-Ab and/or HBs-Ab, which is planned to be treated with 6-8 courses of systemic chemotherapy containing rituximab plus steroid such as R-CHOP, R-CVP, R-THP-COP and R-C-MOPP
JPRN-UMIN000001299agoya City University Hospital321
已完成
不适用
Retrospective, Single-Centre Data Collection Study of the Effectiveness and Safety of a Specially Designed Ductus Arteriosus Self-Expanding Stent (Sinus-SuperFlex-DS, SSF) in the Giessen Hybrid” ApproachQ23.4Hypoplastic left heart syndrome
DRKS00025766optimed Medizinische Instrumente GmbH51
已完成
不适用
Multicenter Retrospective Cohort Study Evaluating the Safety and Efficacy of TAS-102 in Patients with Metastatic Colorectal Cancer; the HGCSG1503 StudyColorectal Cancer
JPRN-UMIN000020551Hokkaido Gastrointestinal Cancer Study Group300
已完成
不适用
Study of telemedicine in prescribing low dose pills for dysmenorrhea patientsdysmenorrhea
JPRN-UMIN000046405Yokohama City University172
Why Are Fertility Preservation Patients Not Coming... | 临床试验